Maintaining Suppression of Testosterone With Transdermal Estradiol Gel
Public ClinicalTrials.gov record NCT02349386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of BHR-200 (0.36% Transdermal Estradiol Gel) for the Maintenance of Testosterone Suppression in Men With Advanced Androgen-Sensitive Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this clinical study is to evaluate the safety and efficacy of three different doses of BHR-200 (0.36% transdermal estradiol gel) compared to placebo for the maintenance of testosterone (T) suppression in men with advanced androgen-sensitive prostate cancer.
Study identification
- NCT ID
- NCT02349386
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2015 (Actual)
- Primary completion
- Jun 14, 2017 (Actual)
- Completion
- Jan 10, 2018 (Actual)
- Last update posted
- Mar 31, 2022
2015 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urological Associates of Southern Arizona | Tucson | Arizona | 85741 | — |
| South Florida Medical Research | Aventura | Florida | 33180 | — |
| Advanced Urology Institute | Daytona Beach | Florida | 32114 | — |
| Adult Pediatric Urology, PC | Council Bluffs | Iowa | 51501 | — |
| Adult Pediatric Urology, PC | Omaha | Nebraska | 68114 | — |
| Delaware Valley Urology | Voorhees Township | New Jersey | 08043 | — |
| AccumetRX Clinical Trials | Albuquerque | New Mexico | 87109 | — |
| Associated Medical Professionals of NY (AMP of NY) | Syracuse | New York | 13210 | — |
| Eastern Urological Associates | Greenville | North Carolina | 27834 | — |
| Urologic Consultants of Southeastern Pennsylvania (UCSEPA) | Bala-Cynwyd | Pennsylvania | 19044 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Clinics of North Texas | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02349386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02349386 live on ClinicalTrials.gov.